点击下方 卡片 ，关注" 自动驾驶之心 "公众号 戳我-> 领取 自动驾驶近15个 方向 学习 路线 Orbis：突破驾驶世界模型长时域预测的技术挑战 弗莱堡大学提出基于流匹配的连续自回归世界模型 Orbis，在仅使用 280 小时单目视频数据和 4.69 亿参数 条件下，长时程预测性能超越现有方法——nuPlan 数据集上 FVD 降至 132.25（6秒预测），转弯场景轨迹 精度（Frechet Precision）提升至 0.47（Table 3）。 主要贡献： 算法框架： Vista 2.000 GEM Cosmos Orbis-MG (ours) 1.500 Orbis (ours) 1,000 500 12 0 8 4 Starting time (s) Figure 4: Video quality (FVD) over consecutive 4s time windows on nuPlan-turns. The x axis shows the starting time of the evaluated time window. 可视化 : Estimated trajectories ...

NextBillion.ai selects TomTom Orbis Maps to deliver enhanced enterprise-grade solutions globally NextBillion.ai selects TomTom Orbis Maps to deliver enhanced enterprise-grade solutions globally AMSTERDAM, June 25, 2025 (GLOBE NEWSWIRE) -- TomTom (TOM2), the location technology specialist, and NextBillion.ai, a leading provider of AI-powered mapping solutions for enterprise, today announced an expanded partnership to deliver precise route calculations and travel time estimations across mobility, fleet, a ...

近日，全球知名的芯片设计公司 ARM 宣布了一项重大战略调整：放弃沿用多年的 Cortex 品牌，并对产 品线进行全面重组，采用全新的产品命名体系。这一决策不仅标志着 ARM 在业务布局上的重大转变， 也反映了其对未来市场竞争态势的深刻洞察。同时，ARM 也对新兴的 RISC-V 架构表达了担忧，认为 其可能对自身业务构成潜在威胁。 ARM 的 Cortex 品牌在半导体行业中拥有极高的知名度，自推出以来，Cortex 系列处理器被广泛应用于 从智能手机到物联网设备等众多领域，为 ARM 奠定了在芯片设计领域的领先地位。然而，随着市场的 快速变化和技术的不断演进，ARM 决定告别这一经典品牌。根据 ARM 发布的官方声明，新的命名体 系将更加简洁明了，有助于客户和合作伙伴更清晰地理解其产品定位和性能特点。通过产品线的重新梳 理，ARM 旨在更好地满足不同市场细分领域的需求，提升自身在全球芯片市场的竞争力。 在新的产品命名体系中，ARM 将运算子系统（Compute Subsystems，CSS）按照不同的应用领域进行了 重新命名。例如，面向基础设施市场的产品被命名为 Arm Neoverse，突出了其在高性能 ...

Core Viewpoint - POLA Group announced the dissolution of its subsidiary, Orbis Trading (Beijing) Co., Ltd., due to significant losses in the Chinese market, totaling over 1.5 billion yen in the past three years, prompting a strategic shift to focus on more stable growth brands and regions [1][5][15]. Group 1: Company Performance and Financials - Orbis Trading (Beijing) Co., Ltd. has reported net sales of 914 million yen, 976 million yen, and 783 million yen for the fiscal years ending in 2022, 2023, and 2024, respectively, with net losses of 570 million yen, 438 million yen, and 605 million yen during the same period [5][6]. - The total registered capital of Orbis Trading (Beijing) Co., Ltd. is 586.8 million USD, and the company has faced challenges due to changes in the Chinese economy and intensified e-commerce competition [5][6]. - POLA Group's overall net sales for 2022, 2023, and 2024 were 166.3 billion yen, 173.3 billion yen, and 170.4 billion yen, respectively, with net profits of 11.4 billion yen, 9.7 billion yen, and 9.3 billion yen [15]. Group 2: Market Strategy and Future Outlook - POLA China clarified that the dissolution of Orbis Trading (Beijing) Co., Ltd. is a localized business optimization and does not affect the operations of other brands in China, which continue to function normally [7]. - The company plans to deepen local innovation and respond actively to Chinese consumer demands, maintaining its commitment to the Chinese market as a long-term strategic core [7]. - Despite the strong growth of the Orbis brand, its overseas revenue contribution remains low, with only 2.5% of total revenue coming from international markets, reflecting a 15.3% decline year-on-year [15].

Core Insights - DarioHealth Corp. reported a revenue of $6.75 million for Q1 2025, marking a 17% increase year-over-year but an 11.2% decrease sequentially due to a shift in scope with a large national health plan client [2][12][5] - The company is strategically positioned to capitalize on trends in healthcare, including the expansion of GLP-1 therapies and the integration of AI in healthcare solutions [2][3] - DarioHealth signed 14 new clients year-to-date, increasing its total client count to 97, with over 80% of new contracts being multi-condition [3][5] Financial Performance - Gross margin improved to 57.5% on a GAAP basis and 70.5% on a non-GAAP basis, reflecting operational efficiencies [4][5] - Total operating expenses decreased by 35% year-over-year to $13.3 million, with non-GAAP operating expenses at $10.6 million [4][17] - The GAAP operating loss decreased by 47% to $9.4 million compared to Q1 2024, while the non-GAAP operating loss narrowed to $5.8 million [7][19] Strategic Initiatives - The company is undergoing an AI transformation aimed at automating workflows and reducing costs, with an expected further 15-20% reduction in operating expenses over the next 12-18 months [6][11] - DarioHealth is focusing on building durable, recurring revenue through high-quality collaborations while phasing out low-margin business [8][9] - Key collaborations have been established to expand Dario's multi-condition offerings, enhancing its value-based care model [9][14] Leadership and Operational Focus - DarioHealth has strengthened its executive leadership team, which is focused on improving execution and operational efficiency [10] - The company has refinanced its debt and raised equity, enhancing its balance sheet and extending its cash runway [11][21] - DarioHealth aims to achieve operational cash flow breakeven by the end of 2025, supported by existing account expansions and new contract wins [5][11]

Financial Data and Key Metrics Changes - Revenue for the first quarter was $82.9 million, down 2% year over year, but within the upper end of guidance [5][27] - Non-GAAP gross margins were 57.7%, up from 51.8% in the previous year, marking a 590 basis points year-over-year expansion [5][27] - Non-GAAP operating expenses were $38.5 million, down $2.2 million from the previous year [5][28] - Non-GAAP EPS was $0.33, compared to $0.09 in Q1 2024, representing significant growth [6][30] - Adjusted EBITDA was $12.5 million, or 15% of sales, compared to $5.6 million in the previous year [29] Business Line Data and Key Metrics Changes - The Americas and European regions saw a revenue decline of 31% each, while the Asia Pacific region experienced a 1% growth [27] - The company launched several new products, including LEAP and BLINK, which are expected to contribute positively to revenue in the upcoming quarters [12][42] Market Data and Key Metrics Changes - The underlying market conditions remained challenging, particularly in the Americas due to tariff-related uncertainties [10][32] - Despite the difficulties, net orders grew by 6% year over year, indicating a positive trend in backlog [9][10] Company Strategy and Development Direction - The company is focused on a three-phase strategy to create shareholder value, with the first phase emphasizing operational excellence and the second phase targeting organic growth [6][7] - The third phase will involve selective higher-risk investments as the company strengthens its cash position [7] - The company aims to refresh its product portfolio and develop global partnerships to drive growth [9][12] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the macro environment, noting that demand is currently outpacing Q1 levels [25][40] - The company is prepared for potential challenges related to tariffs and has plans in place to mitigate impacts [20][21] - Management believes that tariffs could ultimately become a net positive as companies look to diversify supply chains [25] Other Important Information - The company has established a strong cash position, with cash and short-term investments totaling $102.6 million at the end of the quarter [30] - The company is actively managing its partnerships and expects contributions from new agreements in the upcoming quarters [17][18] Q&A Session Summary Question: How is the hardware business shaping up for Q2? - Management noted that while they historically see a larger portion of revenues late in the quarter, they are currently seeing a decent start to Q2, with cautious optimism despite planning for a potential 10% decline in the hardware market [37][39] Question: What is the expected impact of new products on Q2? - Management indicated that new products like LEAP and BLINK are expected to contribute positively in Q2, with strong pre-orders for BLINK already noted [41][42] Question: Can you provide insights on order growth and backlog? - Management clarified that the order growth was not specifically aimed at building backlog, but they did see some late orders that could help solidify their outlook for Q2 [52][55] Question: Are there any delays in product launches or partnerships due to the current environment? - Management confirmed that they do not anticipate delays in product launches or partnerships, viewing the current environment as an opportunity for growth [56][58]

FARO (FARO) Q4 2024 Earnings Call February 24, 2025 04:30 PM ET Company Participants Michael Funari - PartnerPeter Lau - CEO, President & DirectorMatthew Horwath - Senior VP & CFO Conference Call Participants James Ricchiuti - Senior AnalystGreg Palm - Senior Research Analyst Operator Good day, everyone, and welcome to the FARO Technologies Fourth Quarter and Full Year twenty twenty four Earnings Call. At this time, all participants are in a listen only mode. Later, you will have the opportunity to ask ques ...